Phase I Dose Escalation Study of HBI-8000 in Combination

Project: Research project

Project Details

Description

Phase I Dose Escalation Study of HBI-8000 in Combination with Paclitaxel and Trastuzumab in Women with Advanced or Metastatic HER2+ Solid Tumors
StatusFinished
Effective start/end date2/1/164/13/17

Funding

  • HUYA BIOSCIENCE INTERNATIONAL, LLC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.